The going concern warning and AbbVie termination are the dominant signals, but the LightSolver acquisition introduces a binary catalyst. Watch for the registration statement for resale of acquisition shares (due within 75 days of closing) and any subsequent capital raise. The massive milestone warrant overhang (up to 22.2M shares) will likely cap upside until milestones are achieved or shareholder approval is obtained.
Price Chart
Executive Summary
CollPlant reported Q2 2026 financial results showing a GAAP net loss of $2.7 million on revenue of $108,000, down from $179,000 in Q2 2025. The company disclosed a going concern warning, stating available liquidity is insufficient to fund operations for the next 12 months. The filing also details the completed acquisition of LightSolver for photonic computing, which closed on September 3, 2026, and the termination of the AbbVie collaboration agreement in April 2026, eliminating future milestone payments.
Key Facts
- Q2 2026 GAAP net loss of $2.7 million on revenue of $108,000 (down from $179,000 in Q2 2025)
- Six-month 2026 GAAP net loss of $5.8 million on revenue of $181,000 (down from $2.2 million in H1 2025)
- Cash and cash equivalents of $2.6 million as of June 30, 2026, down from $5.6 million at year-end 2025
- Going concern disclosure: available liquidity not sufficient to fund operations for 12 months
- AbbVie terminated the Development Agreement in April 2026, eliminating future milestone and royalty payments
- Acquisition of LightSolver closed September 3, 2026, for 336,103 ordinary shares, pre-funded warrants for 668,448 shares, and milestone warrants for up to 22,231,164 shares
- Reverse stock split of 1-for-10 effective September 4, 2026
- Post-quarter warrant exercises generated approximately $5.2 million in proceeds during August-September 2026
Financial Impact
Revenue declined 92% year-over-year in H1 2026 from $2.2M to $0.2M, driven by loss of $2.0M milestone payment from AbbVie. Cash burn of $5.4M in H1 2026 vs $3.6M in H1 2025. Going concern risk is material.
Risk Factors
- Going concern risk: cash runway insufficient for 12 months without additional financing
- Massive dilution from LightSolver acquisition: up to 22.2 million milestone warrants plus 668,448 pre-funded warrants
- AbbVie termination eliminates key revenue stream from medical aesthetics collaboration
- Integration risk: combining photonic computing startup with cash-constrained biotech
- Nasdaq compliance risk: reverse stock split may not maintain listing if share price declines further
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-105352 |
| Document: ea030677801ex99-1.htm | 0001213900-26-105352 |
| Document: ea030677801ex99-3.htm | 0001213900-26-105352 |
| Document: ea0306778-6k_collplant.htm | 0001213900-26-105352 |
| Document: ea030677801ex10-1.htm | 0001213900-26-105352 |
| Document: 0001213900-26-105352-index-headers.html | 0001213900-26-105352 |
| Document: 0001213900-26-105352-index.html | 0001213900-26-105352 |
| Document: 0001213900-26-105352.txt | 0001213900-26-105352 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 3 | $3.88 $3.76 | ▼ −3.22% | ▼ −3.75% | $3.82 (−1.68%) |
Oct 15, 2026 12d ago | 6-K | $3.68 $3.63 | ▲ +1.49% | ▲ +0.39% | $3.82 (−3.67%) |
Oct 9, 2026 17d ago | 6-K | $4.02 $3.91 | ▲ +2.74% | ▲ +2.72% | $3.82 (+5.10%) |
Oct 8, 2026 18d ago | SC 13G | $3.97 $3.51 | ▼ −11.59% | ▼ −12.19% | $3.82 (−3.90%) |
Oct 8, 2026 18d ago | SC 13D/A | $3.97 $3.51 | ▼ −11.59% | ▼ −12.19% | $3.82 (−3.90%) |
Oct 6, 2026 21d ago | 6-K | $3.39 $3.46 | ▲ +2.06% | ▲ +2.30% | $3.82 (+12.54%) |
Sep 30, 2026 26d ago | 6-K | $3.57 $3.46 | ▲ +3.08% | ▲ +3.82% | $3.82 (−6.86%) |
Sep 30, 2026 26d ago | Press Release | $3.57 $3.46 | ▲ +3.08% | ▲ +3.82% | $3.82 (−6.86%) |
Sep 24, 2026 4w ago | 6-K | $4.12 $4.25 | ▲ +3.16% | ▲ +2.61% | $3.82 (−7.40%) |
Sep 22, 2026 5w ago | 6-K | $3.85 $4.04 | ▲ +4.94% | ▲ +5.66% | $3.82 (−0.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers